Cinctive Capital Management LP Laboratory Corp Of America Holdings Transaction History

Cinctive Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $3.04 Million - $3.49 Million	15,373 New	15,373 $3.49 Million
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $571,220 - $742,190	-2,671 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $4.13 Million - $4.74 Million	-15,893 Reduced 85.61%	2,671 $704,000
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $4.17 Million - $4.82 Million	15,341 Added 475.99%	18,564 $5.83 Million
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $4.56 Million - $5.11 Million	-16,576 Reduced 83.72%	3,223 $907,000
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $2.55 Million - $2.82 Million	10,129 Added 104.75%	19,799 $5.46 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $1.29 Million - $1.61 Million	-6,304 Reduced 39.46%	9,670 $2.47 Million
Q4 2020 Feb 16, 2021	SELL	$186.91 - $214.42 $3.45 Million - $3.95 Million	-18,432 Reduced 53.57%	15,974 $3.25 Million
Q3 2020 Nov 16, 2020	BUY	$167.03 - $201.3 $2.32 Million - $2.8 Million	13,901 Added 67.79%	34,406 $6.48 Million
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $2.32 Million - $3.74 Million	20,505 New	20,505 $3.41 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.